Recombinant human hyaluronidase

recombinant human hyaluronidase (rHuPH20) · Shanghai Henlius Biotech

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Recombinant human hyaluronidase, covering 2011-10-17 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, PK, and Immunogenicity of Recombinant Human Hyaluronidase in Healthy Subjects [Phase 1]

See pricing